These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17875703)
21. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
22. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Fujisawa T; Joshi B; Nakajima A; Puri RK Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609 [TBL] [Abstract][Full Text] [Related]
23. Loss of ONECUT1 expression in human pancreatic cancer cells. Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the tubulin tyrosine ligase-like family member 4 polyglutamylase in PELP1 polyglutamylation and chromatin remodeling in pancreatic cancer cells. Kashiwaya K; Nakagawa H; Hosokawa M; Mochizuki Y; Ueda K; Piao L; Chung S; Hamamoto R; Eguchi H; Ohigashi H; Ishikawa O; Janke C; Shinomura Y; Nakamura Y Cancer Res; 2010 May; 70(10):4024-33. PubMed ID: 20442285 [TBL] [Abstract][Full Text] [Related]
25. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150 [TBL] [Abstract][Full Text] [Related]
26. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Zhang ML; Lu S; Zhou L; Zheng SS Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503 [TBL] [Abstract][Full Text] [Related]
27. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753 [TBL] [Abstract][Full Text] [Related]
28. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155 [TBL] [Abstract][Full Text] [Related]
29. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer]. Hua ZM; Li Z; Lou DL Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930 [TBL] [Abstract][Full Text] [Related]
30. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368 [TBL] [Abstract][Full Text] [Related]
31. Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration. Kucharczak J; Pannequin J; Camby I; Decaestecker C; Kiss R; Martinez J Oncogene; 2001 Oct; 20(48):7021-8. PubMed ID: 11704826 [TBL] [Abstract][Full Text] [Related]
32. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. Glienke W; Maute L; Wicht J; Bergmann L Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508 [TBL] [Abstract][Full Text] [Related]
33. The molecular genetics of pancreatic ductal carcinoma. Sohn TA Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658 [TBL] [Abstract][Full Text] [Related]
34. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900 [TBL] [Abstract][Full Text] [Related]
35. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Shimamura T; Yasuda J; Ino Y; Gotoh M; Tsuchiya A; Nakajima A; Sakamoto M; Kanai Y; Hirohashi S Cancer Res; 2004 Oct; 64(19):6989-95. PubMed ID: 15466191 [TBL] [Abstract][Full Text] [Related]
36. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells. Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747 [TBL] [Abstract][Full Text] [Related]
37. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Ryu B; Jones J; Blades NJ; Parmigiani G; Hollingsworth MA; Hruban RH; Kern SE Cancer Res; 2002 Feb; 62(3):819-26. PubMed ID: 11830538 [TBL] [Abstract][Full Text] [Related]